Mar 19 Soricimed Announces the Appointment of Dr. Marc Rubin and Mr. Vaughn Embro-Pantalony to Board of Directors
/img/newsandevents/San_Fran_thumb.jpg Events Sep 20, 2017 World ADC San Francisco 2017, San Francisco, CA
/img/newsandevents/San_Diego_thumb.jpg Events Jun 4, 2017 2017 BIO International Convention, San Diego, CA
News Sep 27, 2016 Soricimed’s SOR-C13 Granted Orphan Drug Designation for Pancreatic Cancer by the U.S. FDA
/img/newsandevents/San_Fran_thumb.jpg Events Jun 9, 2016 2016 BIO International Convention, San Francisco, CA
/img/newsandevents/San_Diego_thumb.jpg Events May 12, 2016 ACCR (American Academy for Cancer Research) Pancreatic Cancer: Advances in Science and Clinical Care, Orlando, Florida
/img/newsandevents/New_Orleans_thumb.jpg Events Apr 16, 2016 AACR (American Academy for Cancer Research), New Orleans, Louisiana
News Apr 12, 2016 Soricimed Announces Presentations at the Upcoming American Association of Cancer Research (AACR) Annual Meeting
News Mar 8, 2016 Soricimed Granted Orphan-Drug Designation from the U.S. FDA for Treatment of Ovarian Cancer
News Feb 23, 2016 Soricimed Announces Positive Top-Line Results in Phase 1 Trial of First-in-Class Peptide SOR-C13 in Subjects with Advanced Solid Tumour Cancers
News Jan 26, 2016 Soricimed Welcomes Bob Cory, PhD, to Executive Team and Appoints Tom Reeves to Chair
News May 6, 2015 Targeting TRPV6 with Soricimed’s Novel SOR-C13 Inhibits Tumour Growth in Breast and Ovarian Cancer Models
News May 6, 2015 Soricimed’s Findings Support TRPV6 as a Novel and Significant Biomarker for Ovarian Cancer-Targeted Therapies and Diagnostics
News Nov 4, 2013 Toxicology Study of Soricimed’s Anti-Cancer Agent Presented at ACT Conference in San Antonio
News Oct 15, 2013 Soricimed Shows Promise In Treating Breast and Ovarian Cancer With Peptide-Paclitaxel Conjugate
/img/newsandevents/San_Fran_thumb.jpg Events Sep 20, 2013 World ADC San Francisco 2013, San Francisco, CA
News Jul 16, 2013 Soricimed Biopharma Inc. Appoints Tom Reeves to Board of Directors and Welcomes Mario Thomas, PhD, to the Executive Team
News May 28, 2013 Jack Stewart, Chairman and Chief Scientific Officer of Soricimed, speaks on proof-of-concept study results at annual cancer research workshop.
News May 23, 2013 Soricimed Biopharma Inc. Announces U.S. Trial Site for Phase I Clinical Trial of New Cancer Drug, SOR-C13
News Mar 19, 2013 Soricimed’s Peptides Used to Detect Ovarian and Prostate Cancer - Proof of Concept Published in Peer-Reviewed Publication
